409.80CHF-0.44%Mkt Cap: —P/E: 224.301d ago
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$345.19BUSDP/E 24.7
$375.50BUSDP/E 122.7
$348.81BUSDP/E 25.0
$283.47BUSDP/E 22.7
$276.41BUSDP/E 23.7
$234.02BUSDP/E 25.0
$240.45BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$142.58BUSDP/E 38.5
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$130.23BUSDP/E 32.1
Key Statistics
Company
Market Cap—
Enterprise Value6.44B $
Revenue (TTM)834.27M $
Gross Profit359.06M $
Net Income (TTM)253.29M $
Revenue/Share61.31 USD
Last Price409.80 CHF
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2.0K
CountryGB
SectorHealthcare
Industry—
ISINCH0019396990
Valuation
P/E (Trailing)224.30
P/E (Forward)—
PEG—
EV/EBITDA17.33
EV/Revenue7.72
P/S—
P/B7.24
EPS (TTM)1.83
EPS (Forward)—
52W Range
408.4016% of range417.00
52W High417.00 CHF
52W Low408.40 CHF
Profitability
Gross Margin43.04%
Oper. Margin26.45%
EBITDA Margin44.57%
Profit Margin30.36%
ROE31.09%
ROA12.36%
Growth
Revenue Growth-13.30%
Earnings Growth51.70%
Cash Flow & Leverage
Operating CF350.11M $
CapEx (TTM)—
FCF Margin-7.83%
FCF Yield—
Net Debt265.02M $
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity34.86
Current Ratio1.07
Quick Ratio0.73
Book Value/Sh56.91 CHF
Cash/Share2.172 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate4.400 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.60M
Float3.51M
Insiders74.53%
Institutions15.42%
Technical
SMA 50327.99 (+24.9%)
SMA 200281.05 (+45.8%)
Beta0.77
S&P 52W Chg20.80%
Avg Vol (30d)1.87K
Avg Vol (10d)2.07K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—